Related medicinesMacimorelinAnamorelin
Where it comes from
- Made in
- Endocrine cells in the lining of the stomach, mostly the fundus, with less from the small intestine and pancreas
- Sent out by
- Fasting: levels climb before an expected meal and fall within an hour of eating
- Acts on
- Hypothalamus (NPY and AgRP neurons)
- Pituitary
- Vagus nerve
- Pancreas
What it does
- Signals hunger and starts meals
- Releases growth hormone from the pituitary 1
- Favours fat storage and raises blood glucose
In medicine
- Macimorelin, an oral ghrelin receptor agonist, is approved to diagnose growth hormone deficiency in adults
- Anamorelin is approved in Japan for the weight loss of cancer
- Ghrelin falls in the months after gastric bypass in many studies, though not all; how much it explains the loss of appetite is debated
Beyond the body’s own use
- The “growth hormone secretagogues” ipamorelin, GHRP-2, GHRP-6 and hexarelin, and the oral MK-677 (ibutamoren), all imitate ghrelin at its receptor, and none is an approved medicine. In 65 healthy older adults given MK-677 for a year, fat-free mass rose by about a kilogram, but fasting glucose rose too and insulin sensitivity fell 2
- Peptides of this family obtained outside the approved supply are not reviewed for safety, effectiveness or quality, and the whole class is banned in sport at all times 4
- Anamorelin was refused in Europe in 2017: the regulator found the gain in lean mass small and no improvement in grip strength or in how patients felt 3
- Ghrelin itself has been infused in studies of appetite in cancer and chronic illness. It lasts minutes in the blood, which is why no infusion has become a treatment 1
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.